Alymova IV - Search Results

1

The novel parainfluenza virus hemagglutinin-neuraminidase inhibitor BCX 2798 prevents lethal synergism between a paramyxovirus and Streptococcus pneumoniae.

Alymova IV, Portner A, Takimoto T, Boyd KL, Babu YS, McCullers JA. Alymova IV, et al. Antimicrob Agents Chemother. 2005 Jan;49(1):398-405. doi: 10.1128/AAC.49.1.398-405.2005. Antimicrob Agents Chemother. 2005. PMID: 15616320 Free PMC article.

2

Efficacy of novel hemagglutinin-neuraminidase inhibitors BCX 2798 and BCX 2855 against human parainfluenza viruses in vitro and in vivo.

Alymova IV, Taylor G, Takimoto T, Lin TH, Chand P, Babu YS, Li C, Xiong X, Portner A. Alymova IV, et al. Antimicrob Agents Chemother. 2004 May;48(5):1495-502. doi: 10.1128/AAC.48.5.1495-1502.2004. Antimicrob Agents Chemother. 2004. PMID: 15105096 Free PMC article.

3

Loss of the N-linked glycan at residue 173 of human parainfluenza virus type 1 hemagglutinin-neuraminidase exposes a second receptor-binding site.

Alymova IV, Taylor G, Mishin VP, Watanabe M, Murti KG, Boyd K, Chand P, Babu YS, Portner A. Alymova IV, et al. J Virol. 2008 Sep;82(17):8400-10. doi: 10.1128/JVI.00474-08. Epub 2008 Jun 25. J Virol. 2008. PMID: 18579600 Free PMC article.

4

Effect of hemagglutinin-neuraminidase inhibitors BCX 2798 and BCX 2855 on growth and pathogenicity of Sendai/human parainfluenza type 3 chimera virus in mice.

Watanabe M, Mishin VP, Brown SA, Russell CJ, Boyd K, Babu YS, Taylor G, Xiong X, Yan X, Portner A, Alymova IV. Watanabe M, et al. Among authors: alymova iv. Antimicrob Agents Chemother. 2009 Sep;53(9):3942-51. doi: 10.1128/AAC.00220-09. Epub 2009 Jun 29. Antimicrob Agents Chemother. 2009. PMID: 19564364 Free PMC article.

5

Efficacy of the novel parainfluenza virus haemagglutinin-neuraminidase inhibitor BCX 2798 in mice - further evaluation.

Alymova IV, Watanabe M, Boyd KL, Chand P, Babu YS, Portner A. Alymova IV, et al. Antivir Ther. 2009;14(7):891-8. doi: 10.3851/IMP1420. Antivir Ther. 2009. PMID: 19918093 Free PMC article.

6

Receptor-binding specificity of the human parainfluenza virus type 1 hemagglutinin-neuraminidase glycoprotein.

Alymova IV, Portner A, Mishin VP, McCullers JA, Freiden P, Taylor GL. Alymova IV, et al. Glycobiology. 2012 Feb;22(2):174-80. doi: 10.1093/glycob/cwr112. Epub 2011 Aug 16. Glycobiology. 2012. PMID: 21846691 Free PMC article.

7

Neuraminidase inhibitors as antiviral agents.

Alymova IV, Taylor G, Portner A. Alymova IV, et al. Curr Drug Targets Infect Disord. 2005 Dec;5(4):401-9. doi: 10.2174/156800505774912884. Curr Drug Targets Infect Disord. 2005. PMID: 16535861 Review.

8

N-linked glycan at residue 523 of human parainfluenza virus type 3 hemagglutinin-neuraminidase masks a second receptor-binding site.

Mishin VP, Watanabe M, Taylor G, Devincenzo J, Bose M, Portner A, Alymova IV. Mishin VP, et al. Among authors: alymova iv. J Virol. 2010 Mar;84(6):3094-100. doi: 10.1128/JVI.02331-09. Epub 2010 Jan 6. J Virol. 2010. PMID: 20053750 Free PMC article.

9

Immunopathogenic and antibacterial effects of H3N2 influenza A virus PB1-F2 map to amino acid residues 62, 75, 79, and 82.

Alymova IV, Green AM, van de Velde N, McAuley JL, Boyd KL, Ghoneim HE, McCullers JA. Alymova IV, et al. J Virol. 2011 Dec;85(23):12324-33. doi: 10.1128/JVI.05872-11. Epub 2011 Sep 21. J Virol. 2011. PMID: 21937639 Free PMC article.

10

Non-avian animal reservoirs present a source of influenza A PB1-F2 proteins with novel virulence-enhancing markers.

Alymova IV, York IA, McCullers JA. Alymova IV, et al. PLoS One. 2014 Nov 4;9(11):e111603. doi: 10.1371/journal.pone.0111603. eCollection 2014. PLoS One. 2014. PMID: 25368997 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

22 results

Search Page

Filters